Peptide-based methods for treating pancreatic cancer
AssigneesThe United States of America, as represented by the Secretary, Dept. of Health and Human Services, Riptide Bioscience, Inc.
InventorsUdo Rudloff, Jesse M. Jaynes, Henry W. Lopez, George R. Martin, Clayton Yates
Life of this patent
Estimating the term…
Abstract
Methods for treating a subject for pancreatic cancer via administration of small anti-inflammatory peptides are disclosed. The peptides may be administered in conjunction with another therapeutic agent, such as a chemotherapeutic agent, or therapeutic regimen. In some cases, the anti-inflammatory peptide that finds use in the subject methods has the amino acid sequence Lys-Phe-Arg-Lys-Ala-Phe-Lys-Arg-Phe-Phe (SEQ ID NO:1) or a multimer, derivative, or variant thereof.
Claims17
A method for treating pancreatic cancer in a subject comprising administering to the subject in need thereof a peptide comprising the amino acid sequence Lys-Phe-Arg-Lys-Ala-Phe-Lys-Arg-Phe-Phe (SEQ ID NO:1) or a multimer, derivative, or variant thereof.
Dependencies are inferred from the claim text.